COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 2912: Articles 29111-29120  | Next

Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus
Ngonghala, C. N., Iboi, E., Eikenberry, S., Scotch, M., MacIntyre, C. R., Bonds, M. H., Gumel, A. B.
10.1101/2020.04.15.20066480 — Posted: 2020-04-18
Social Isolation as a predictor for mortality: Implications for COVID-19 prognosis
Banerjee, S., Burkholder, G., Sana, B., Szirony, M.
10.1101/2020.04.15.20066548 — Posted: 2020-04-18
Meteorological factors and domestic new cases of coronavirus disease (COVID-19) in nine Asian cities: A time-series analysis
He, Z., Chin, Y., Huang, J., He, Y., Akinwunmi, B. O., Yu, S., Zhang, C. J. P., Ming, W.-k.
10.1101/2020.04.15.20066613 — Posted: 2020-04-18
Analysis of the mitigation strategies for COVID-19: from mathematical modelling perspective
Kassa, S., Njagarah, H. J. B., Terefe, Y. A.
10.1101/2020.04.15.20066308 — Posted: 2020-04-18
SARS-Cov-2 RNA Found on Particulate Matter of Bergamo in Northern Italy: First Preliminary Evidence
Setti, L., Passarini, F., De Gennaro, G., Baribieri, P., Perrone, M. G., Borelli, M., Palmisani, J., Di Gilio, A., Torboli, V., Pallavicini, A., Ruscio, M., PISCITELLI, P., Miani, A.
10.1101/2020.04.15.20065995 — Posted: 2020-04-18 Discussion: Onsite
A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases
Geifman, N., Whetton, A. D.
10.1101/2020.04.15.20065425 — Posted: 2020-04-18
Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients
Wang, X., Guo, X., Xin, Q., Chu, Y., Li, J., Pan, Y., Feng, Y., Wang, Q.
10.1101/2020.04.15.20065623 — Posted: 2020-04-18 Discussion: Onsite
Impact of healthcare worker shift scheduling on workforce preservation during the COVID-19 pandemic
Kluger, D. M., Aizenbud, Y., Jaffe, A., Aizenbud, L., Parisi, F., Minsky-Fenick, E., Kluger, J. M., Farhadian, S., Kluger, H. M., Kluger, Y.
10.1101/2020.04.15.20061168 — Posted: 2020-04-18
The impact of early scientific literature in response to COVID-19: a scientometric perspective
Golinelli, D., Nuzzolese, A. G., Boetto, E., Rallo, F., Greco, M., Toscano, F., Fantini, M. P.
10.1101/2020.04.15.20066183 — Posted: 2020-04-18
Lack of coordination and medical disinformation in Canadian self-assessment tools for COVID-19
Olibris, B., Attaran, A.
10.1101/2020.04.14.20065631 — Posted: 2020-04-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).